Cogent Biosciences, Inc. (COGT)
31.15
+0.13
(+0.42%)
USD |
NASDAQ |
Jun 08, 16:00
31.15
0.00 (0.00%)
After-Hours: 20:00
Cogent Biosciences Market Cap : 5.321B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vera Therapeutics, Inc. | 2.275B |
| Replimune Group, Inc. | 715.49M |
| Vir Biotechnology, Inc. | 1.362B |
| Revolution Medicines, Inc. | 29.73B |
| Vaxcyte, Inc. | 6.686B |
Market Cap Related Metrics
| PEG Ratio | -2.714 |
| Price to Book Value | 9.800 |
| Price | 31.15 |
| Earnings Yield | -8.10% |
| PEGY Ratio | -2.714 |